Log in to MyKarger to check if you already have access to this content.

Buy FullText & PDF Unlimited re-access via MyKarger Unrestricted printing, no saving restrictions for personal use read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!

If you would like to redeem your KAB credit, please log in.

Save over 20% compared to the individual article price.

Learn more

Rent via DeepDyve Unlimited fulltext viewing of this article Organize, annotate and mark up articles Printing and downloading restrictions apply

Start free trial

Subscribe Access to all articles of the subscribed year(s) guaranteed for 5 years Unlimited re-access via Subscriber Login or MyKarger Unrestricted printing, no saving restrictions for personal use read more

Subcription rates

Select

* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview

Received: September 15, 2022
Accepted: December 22, 2022
Published online: February 22, 2023

Number of Print Pages: 7
Number of Figures: 2
Number of Tables: 2

ISSN: 0042-1138 (Print)
eISSN: 1423-0399 (Online)

For additional information: https://www.karger.com/UIN

Abstract

Introduction: Urolithiasis is one of the most common diseases in the world, and at present, ureteroscopy (URS) is the first choice for its treatment. Although the effect is good, there is a risk of insertion failure of ureteroscope. Tamsulosin, as an α-receptor blocker, has the function of relaxing ureteral muscles, and can help stones to be discharged from ureteral orifice. In this study, we aimed to determine the effect of preoperative tamsulosin on ureteral navigation, operation, and safety. Methods: This study was conducted and reported according to the meta-analysis extension of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). The PubMed and Embase databases were searched for studies. Data were extracted according to the PRISMA principles. We collected and combined randomized controlled trial and researches in reviews of preoperative tamsulosin to explore the effect of preoperative tamsulosin on ureteral navigation, operation, and safety. A data synthesis was performed using RevMan 5.4.1 software (Cochrane). Heterogeneity was mainly evaluated with I2 tests. Key metrics include: success rate of ureteral navigation, time of URS, stone-free rate, and postoperative symptoms. Result: We summarized and analyzed 6 studies. We noted a statistically significant improvement in the success rate of ureteral navigation (Mantel-Haenszel [M-H], odds ratio [OR]: 3.78, 95% confidence interval [CI]: [2.34, 6.12], p < 0.01) and stone-free rate (M-H, OR: 2.25, 95% CI: [1.16, 4.36], p = 0.02) with tamsulosin preoperatively. At the same time, we also observed that postoperative fever (M-H, OR: 0.37, 95% CI: [0.16, 0.89], p = 0.03) and postoperative analgesia (M-H, OR: 0.21, 95% CI: [0.05, 0.92], p = 0.04) were also reduced because of preoperative tamsulosin. Conclusion: Preoperative tamsulosin can not only increase the one-time success rate of ureteral navigation and the stone-free rate of URS but also reduce the incidence of postoperative adverse symptoms such as postoperative fever and postoperative pain.

© 2023 S. Karger AG, Basel

References Ketabchi AA, Mehrabi S. The effect of tamsulosin, an alpha-1 receptor antagonist as a medical expelling agent in success rate of ureteroscopic lithotripsy. Nephrourol Mon. 2014;6(1):e12836. Bangash M, Nazim SM, Jamil S, Abdul Ghani MO, Naeem S. Efficacy and safety of semi-rigid ureteroscopic lithotripsy (URS) for proximal ureteral stone ≥10 mm. J Coll Physicians Surg Pak. 2020;30(10):1058–62. Wang SJ, Mu XN, Zhang LY, Liu QY, Jin XB. The incidence and clinical features of acute kidney injury secondary to ureteral calculi. Urol Res. 2012;40(4):345–8. Kim SS, Kolon TF, Canter D, White M, Casale P. Pediatric flexible ureteroscopic lithotripsy: the children's hospital of Philadelphia experience. J Urol. 2008;180(6):2616–9; discussion 2619. Resorlu B, Sancak EB, Resorlu M, Gulpinar MT, Adam G, Akbas A, et al. Retrograde intrarenal surgery in pediatric patients. World J Nephrol. 2014;3(4):193–7. Van Batavia JP, Tasian GE. Clinical effectiveness in the diagnosis and acute management of pediatric nephrolithiasis. Int J Surg. 2016;36(Pt D):698–704. Schneck F, Ost MJWA, Kavoussi LR, Partin AW, Peter CA. Cambell-walsh urology In: Surgical management of pediatric stone disease. 11th ed. Philadelphia: Elsevier; 2016. p. 3102–20. Itoh Y, Okada A, Yasui T, Hamamoto S, Hirose M, Kojima Y, et al. Efficacy of selective α1A adrenoceptor antagonist silodosin in the medical expulsive therapy for ureteral stones. Int J Urol. 2011;18(9):672–4. Türk C, Knoll T, Seitz C, Skolarikos A, Chapple C, McClinton S, et al. Medical expulsive therapy for ureterolithiasis: the EAU recommendations in 2016. Eur Urol. 2017;71(4):504–7. Conway JC, Friedman BW. Medical expulsive therapy (alpha blockers) for urologic stone disease. Acad Emerg Med. 2020;27(9):923–4. Basri C, Sinanoglu O, Mahmure U. The effect of tamsulosin on pain and clearance according to ureteral stone location after shock wave lithotripsy. Curr Ther Res Clin Exp. 2013;74:33–5. Oestreich MC, Vernooij RW, Sathianathen NJ, Hwang EC, Kuntz GM, Koziarz A, et al. Alpha-blockers after shock wave lithotripsy for renal or ureteral stones in adults. Cochrane Database Syst Rev. 2020;11(11):CD013393. Aydın M, Kılınç MF, Yavuz A, Bayar G. Do alpha-1 antagonist medications affect the success of semi-rigid ureteroscopy? A prospective, randomised, single-blind, multicentric study. Urolithiasis. 2018;46(6):567–72. Abdelaziz AS, Kidder AM. Tamsulosin therapy improved the outcome of ureterorenoscopy for lower ureteral stones: a prospective, randomised, controlled, clinical trial. Afr J Urol. 2017;23(2):148–53. Page MJ, Moher D. Evaluations of the uptake and impact of the preferred reporting Items for systematic reviews and meta-analyses (PRISMA) statement and extensions: a scoping review. Syst Rev. 2017;6(1):263. Eriksen MB, Frandsen TF. The impact of patient, intervention, comparison, outcome (PICO) as a search strategy tool on literature search quality: a systematic review. J Med Libr Assoc. 2018;106(4):420–31. Tawfeek AM, Abdelwahab MS, Higazy A, Radwan A, Swar SA, Shaker H, et al. Effect of perioperative selective alpha-1 blockers in non-stented ureteroscopic laser lithotripsy for ureteric stones: a randomized controlled trial. Cent Eur J Urol. 2020;73(4):520–5. Morley C, Hajiran A, Elbakry AA, Al-Qudah HS, Al-Omar O. Evaluation of preoperative tamsulosin role in facilitating ureteral orifice navigation for school-age pediatric ureteroscopy. Res Rep Urol. 2020;12:563–8. McGee LM, Sack BS, Wan J, Kraft KH. The effect of preoperative tamsulosin on ureteroscopic access in school-aged children. J Pediatr Urol. 2021;17(6):795.e1–6. Kaler KS, Safiullah S, Lama DJ, Parkhomenko E, Okhunov Z, Ko YH, et al. Medical impulsive therapy (MIT): the impact of 1 week of preoperative tamsulosin on deployment of 16-French ureteral access sheaths without preoperative ureteral stent placement. World J Urol. 2018;36(12):2065–71. Kaler KKS, Safiullah S, Patel R, Lama D, Ko Y, Okhunov Z, et al. The impact of one week of preoperative tamsulosin on deployment of 16 French ureteral access sheaths. Can Urol Assoc J. 2017;11(6):S259–60. Demir M, Ertas K, Aslan R, Eryilmaz R, Sevim M, Taken K. Does tamsulosin use before ureteroscopy increase the success of the operation? J Coll Physicians Surg Pak. 2022;32(2):197–201. Li X, Zhu W, Lam W, Yue Y, Duan H, Zeng G. Outcomes of long-term follow-up of asymptomatic renal stones and prediction of stone-related events. BJU Int. 2019;123(3):485–92. Pickard R, Starr K, MacLennan G, Lam T, Thomas R, Burr J, et al. Medical expulsive therapy in adults with ureteric colic: a multicentre, randomised, placebo-controlled trial. Lancet. 2015;386(9991):341–9. De Coninck V, Antonelli J, Chew B, Patterson JM, Skolarikos A, Bultitude M. Medical expulsive therapy for urinary stones: future trends and knowledge gaps. Eur Urol. 2019;76(5):658–66. Geavlete P, Multescu R, Geavlete B. Pushing the boundaries of ureteroscopy: current status and future perspectives. Nat Rev Urol. 2014;11(7):373–82. Schmidt S, Miernik A. [Alpha-blockers as medical expulsive therapy for ureteral stones]. Urologe A. 2016;55(6):813–6. Hu Q, Ji Y, Wang Z, Lai Y, Deng Q, Zhang J, et al. Is a ureteral stent required before flexible ureteroscopy? Transl Androl Urol. 2020;9(6):2723–9. Article / Publication Details

First-Page Preview

Received: September 15, 2022
Accepted: December 22, 2022
Published online: February 22, 2023

Number of Print Pages: 7
Number of Figures: 2
Number of Tables: 2

ISSN: 0042-1138 (Print)
eISSN: 1423-0399 (Online)

For additional information: https://www.karger.com/UIN